Webinar | Out of the Shadows: A Step-by-Step Approach to AI Governance Discover how to move beyond the restrictive "block or allow" debate and turn unauthorized AI adoption into a strategic catalyst for transformation.
Nominate Now | Top 30 Healthcare Innovators 2026 List Honoring the Executives Driving Measurable Transformation and Responsible Innovation Across the Healthcare Ecosystem.
CDO Magazine Unveils the 40 Most Influential Data Leaders in Finance — North America 2026 Few industries are advancing data and AI as rapidly as financial services. From real-time payments and fraud detection to risk modeling, regulatory compliance, and AI-driven customer experiences, fina...
Podcasts
PODCAST | A Deep-dive into Takeda’s AI Foundations – With Head of Data Steve Winawer
Written by: CDO Magazine
Updated 12:00 PM UTC, August 31, 2025
Takeda Pharmaceutical Company is one of the world’s largest biopharmaceutical firms, known for its science-driven innovation. In this CDO Magazine interview, Steve Winawer, Head of Data, Digital, and Technology for the US Business Unit, speaks with Dave McEachern, Managing Director at AHEAD, about how Takeda ensures data trust, quality, and compliance before diving into AI solutions.
You’ll learn:
- Why AI projects start with the right business problem
- How Takeda adapts to 22 unique US state privacy laws
- The company’s evolving approach to digital data and automation
This is Part 1 of a two-part series. Listen now and explore the blueprint for trusted AI in pharma.
CHECK OUT MORE EPISODES
Elevate Your Personal Brand
